A new way to classify tuberculosis (TB) that aims to improve focus on the early stages of the disease has been presented by an international team involving researchers at UCL (University College ...

A new way to classify tuberculosis (TB) that aims to improve focus on the early stages of the disease has been launched by an international team including researchers from the London School of Hygiene ...

(Philadelphia, PA) - A worldwide health problem, tuberculosis kills more people than any other bacterial infection. The World Health Organization estimates that two billion people are infected with TB ...

Infection by Mycobacterium tuberculosis kills 1.5 million people worldwide every year. Antibiotics to treat TB exist, but in recent years, multi-drug resistant (MDR), extensively drug-resistant (XDR) ...

A team of Rutgers University scientists led by Richard H. Ebright and Eddy Arnold has identified a new antibiotic target and a new antibiotic mechanism that may enable the development of ...

Eighty years after the discovery of penicillin, researchers say they are on the verge of developing a new class of antibiotics. Publishing in the Oct. 17 issue of the journal Cell, scientists at ...

SEONGNAM-SI, Korea--(BUSINESS WIRE)--Qurient Co. Ltd. today announced the publication in the New England Journal of Medicine (NEJM) of positive results from the Phase 2 clinical trial for telacebec ...

TMC207 is a first-in-class anti-TB diarylquinoline (also named R207910 or the 'J' compound) with activity against drug-sensitive and drug-resistant TB. TMC207 inhibits the proton pump of mycobacterial ...